Genprex, Inc. (GNPX)
2.20
+0.24
(+12.24%)
USD |
NASDAQ |
Feb 06, 16:00
2.24
+0.04
(+1.82%)
After-Hours: 20:00
Genprex EPS Diluted (Quarterly) : -4.996 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arvinas, Inc. | -0.4795 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.799M |
| Total Expenses (Quarterly) | 3.799M |
| Enterprise Value | 1.106M |
| Earnings Yield | -1.59K% |
| Normalized Earnings Yield | -1588.12 |